Protein points to fibromatosis recurrence

Chinese researchers at the Children's Hospital of Fudan University in Shanghai have tracked down a biomarker that could tag those fibromatosis patients whose tumor is likely to recur. Aggressive fibromatosis is a slow-growing and rare benign tumor that only occurs in around two to four people per million. However, it often comes back after surgery, especially in children. The researchers looked at samples of the tumor from children and found raised levels of the protein beta-catenin, in those whose tumors were particularly aggressive. They also found a mutation in the gene coding for the protein. The research was published in Pediatric and Developmental Pathology. Press release  | Abstract

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.